Gene · 6370
Papers1,976
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,976
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The immune checkpoint adenosine 2A receptor is associated with aggressive clinical outcomes and reflects an immunosuppressive tumor microenvironment in human breast cancer. | Front Immunol | 2023 | 37753093 | PubTator, text mining | PubMed |
| CCR9 overexpression promotes T-ALL progression by enhancing cholesterol biosynthesis. | Front Pharmacol | 2023 | 37745085 | PubTator, text mining | PubMed |
| Regenerating gene 4 promotes chemoresistance of colorectal cancer by affecting lipid droplet synthesis and assembly. | World J Gastroenterol | 2023 | 37744296 | PubTator, text mining | PubMed |
| A novel chemokine biomarker to distinguish active tuberculosis from latent tuberculosis: a cohort study. | QJM | 2023 | 37740371 | PubTator, text mining | PubMed |
| Metastatic Gastric Mucosal Melanoma: A Rare Case Presenting With Diffuse Gastric Polyposis. | Cureus | 2023 | 37727165 | PubTator, text mining | PubMed |
| NASH Drug Development: Seeing the Light at the End of the Tunnel? | J Clin Transl Hepatol | 2023 | 37719961 | PubTator, text mining | PubMed |
| Survival and biomarkers for cachexia in non-small cell lung cancer receiving immune checkpoint inhibitors. | Cancer Med | 2023 | 37712645 | PubTator, text mining | PubMed |
| A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma. | Transl Cancer Res | 2023 | 37701098 | PubTator, text mining | PubMed |
| Facts and prospects of peptide in targeted therapy and immune regulation against triple-negative breast cancer. | Front Immunol | 2023 | 37691919 | PubTator, text mining | PubMed |
| Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer. | Cardiovasc Toxicol | 2023 | 37684436 | PubTator, text mining | PubMed |
| The lung-gut crosstalk in respiratory and inflammatory bowel disease. | Front Cell Infect Microbiol | 2023 | 37680747 | PubTator, text mining | PubMed |
| Memory T Cells in the Immunoprevention of Cancer: A Switch from Therapeutic to Prophylactic Approaches. | J Immunol | 2023 | 37669503 | PubTator, text mining | PubMed |
| Comprehensive analysis of ACKR family members in breast cancer using prognostic values. | Oncol Lett | 2023 | 37664667 | PubTator, text mining | PubMed |
| Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trial. | EClinicalMedicine | 2023 | 37654670 | PubTator, text mining | PubMed |
| Deciphering pathogenic cellular module at single-cell resolution in checkpoint inhibitor-related pneumonitis. | Oncogene | 2023 | 37653115 | PubTator, text mining | PubMed |
| Semaphorins in immune cell function, inflammatory and infectious diseases. | Curr Res Immunol | 2023 | 37645659 | PubTator, text mining | PubMed |
| Genetics of Plasma Bilirubin and Associations between Bilirubin and Cardiometabolic Risk Profiles in Danish Children and Adolescents. | Antioxidants (Basel) | 2023 | 37627608 | PubTator, text mining | PubMed |
| Downregulation of chemokine receptor 9 facilitates CD4+CD8αα+ intraepithelial lymphocyte development. | Nat Commun | 2023 | 37620389 | PubTator, text mining | PubMed |
| The Role of IgA in the Manifestation and Prevention of Allergic Immune Responses. | Curr Allergy Asthma Rep | 2023 | 37610671 | PubTator, text mining | PubMed |
| Long non-coding RNAs as the critical regulators of PI3K/AKT, TGF-β, and MAPK signaling pathways during breast tumor progression. | J Transl Med | 2023 | 37596669 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6370/papers?page=11